Long-term cognitive functioning following COVID-19: Negligible neuropsychological changes over time
<b>Objective:</b> Objective cognitive impairment has been shown in a minority of hospitalized COVID-19 patients, and longitudinal studies with a relatively long follow-up duration are scarce. We sought to investigate the presence and long-term change of objective cognitive functioning. <b>Method:</b> Forty-six initially hospitalized (18 ± 19 days) COVID-19 survivors (male/female: 30/16; age: 61 ± 11) underwent extensive neuropsychological assessment (including performance validity) approximately 1 (T1) and 2.5 years (T2) post-infection. Cognitive domains assessed were: memory, attention, executive functioning, processing speed, and language (<i>n</i> = 14 (sub)tests). We used normative data to derive age, sex, and education-adjusted T-scores (<i>T</i> ≤ 35 [≤-1.5SD], deficit cut-off). Repeated measures AN(C)OVAs were used to investigate cognitive functioning over time. <b>Results:</b> Mean neuropsychological performance (<i>n</i> = 14 tests) was within normal range at both timepoints, and number of individuals with objective cognitive deficits ranged from 0-20% (T1), and 2-22% (T2). Number of subjective cognitive complaints remained unchanged. A minority (17%) showed objective cognitive deficits on ≥2 tests at both 1 and 2.5 years post-infection, but not consistently within one cognitive domain. Longitudinal analyses on the total sample showed improvement in performance over time on phonemic fluency (<i>p</i><.001), but stable cognitive performance on all other tests, independent of prior comorbidities, subjective cognitive complaints, depressive symptoms, and ICU admission. <b>Conclusions:</b> There were no consistent objective cognitive deficits or major cognitive disorders years after SARS-CoV-2 infection in the majority of cases. Neuropsychological functioning remained essentially unchanged over time. Future larger longitudinal studies are necessary to unravel COVID-19-related cognitive phenotypes of persisting deficits and how these can be modulated.
Authors
- Janneke Horn (ORCID: https://orcid.org/0000-0002-3788-7675)
- Simona Klinkhammer (ORCID: https://orcid.org/0000-0001-7008-0323)
- Hans Knoop (ORCID: https://orcid.org/0000-0001-7763-3517)
- Anouk Verveen (ORCID: https://orcid.org/0000-0002-8798-3390)
- Esmée Verwijk
- Caroline M Van Heugten (ORCID: https://orcid.org/0000-0003-4272-7315)
- Denise Visser (ORCID: https://orcid.org/0000-0002-3642-146X)
- Sander C.J. Verfaillie (ORCID: https://orcid.org/0000-0003-1820-3378)
- Bart N.M. van Berckel (ORCID: https://orcid.org/0000-0003-1811-4383)
- Dook W. Koch
- Pythia T. Nieuwkerk (ORCID: https://orcid.org/0000-0002-2616-1414)
- Nelleke Tolboom (ORCID: https://orcid.org/0000-0002-8005-2833)
Institutions
- University Medical Center Utrecht (NL)
- Maastricht University (NL)
- Amsterdam Neuroscience (NL)
- GGZ inGeest (NL)
- GGD Amsterdam (NL)
- Amsterdam University Medical Centers (NL)
- University of Amsterdam (NL)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
Publication Details
- Journal
- The Clinical Neuropsychologist
- Published
- 2025-05-02
- DOI
- https://doi.org/10.1080/13854046.2025.2496212
- Citations
- 1
- Primary Topic
- Long-Term Effects of COVID-19
- Type
- article
- Field-Weighted Citation Impact
- 1.39
Funders
- ZonMw